Eli Lilly Files 2024 10-K, Details Financials
Ticker: LLY · Form: 10-K · Filed: 2025-02-19T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, debt
TL;DR
LLY dropped its 2024 10-K. All looks good, debt due in '25, '26, '30.
AI Summary
Eli Lilly and Company (LLY) filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, a major player in pharmaceutical preparations, is incorporated in Indiana and headquartered in Indianapolis. The filing covers various financial aspects, including notes due in 2025, 2026, and 2030, and details its business operations and financial performance for the year.
Why It Matters
This 10-K filing provides a comprehensive overview of Eli Lilly's financial health and operational status for 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual financial filing for a large, established company, providing routine disclosures.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (Date the fiscal year concluded)
- 20250219 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- ELI LILLY & Co (company) — Filer
- 0000059478 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- Indianapolis (company) — Headquarters City
- IN (company) — Headquarters State
- 3172762000 (company) — Business Phone Number
- 20241231 (date) — Fiscal Year End
- 20250219 (date) — Filing Date
- LLY:A718NotesDueJune12025Member (dollar_amount) — Debt Instrument
- LLY:A1.625NotesDueJune22026Member (dollar_amount) — Debt Instrument
FAQ
What is Eli Lilly and Company's primary industry classification?
Eli Lilly and Company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
When did Eli Lilly and Company's fiscal year end for this report?
The conformed period of report for this 10-K filing is December 31, 2024.
What is the filing date of this 10-K report?
This 10-K report was filed as of February 19, 2025.
Where is Eli Lilly and Company headquartered?
Eli Lilly and Company is headquartered in Indianapolis, IN.
What are some of the debt instruments mentioned in the filing details?
The filing details mention debt instruments such as LLY:A718NotesDueJune12025Member, LLY:A1.625NotesDueJune22026Member, and LLY:A2.125NotesDueJune32030Membe.
From the Filing
0000059478-25-000067.txt : 20250219 0000059478-25-000067.hdr.sgml : 20250219 20250219101059 ACCESSION NUMBER: 0000059478-25-000067 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 132 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250219 DATE AS OF CHANGE: 20250219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 25637747 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 10-K 1 lly-20241231.htm 10-K lly-20241231 true false FALSE 2024 FY 0000059478 http://fasb.org/us-gaap/2024#RestructuringSettlementAndImpairmentProvisions http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent P1Y P3Y http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent 1 251 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure lly:right iso4217:EUR iso4217:CNY iso4217:JPY lly:patent lly:site iso4217:BRL lly:segment 0000059478 2024-01-01 2024-12-31 0000059478 us-gaap:CommonClassAMember 2024-01-01 2024-12-31 0000059478 lly:A718NotesDueJune12025Member 2024-01-01 2024-12-31 0000059478 lly:A1.625NotesDueJune22026Member 2024-01-01 2024-12-31 0000059478 lly:A2.125NotesDueJune32030Member 2024-01-01 2024-12-31 0000059478 lly:A625Notesdue2031Member 2024-01-01 2024-12-31 0000059478 lly:A.5000EuroDenominatedNotesDue2033Member 2024-01-01 2024-12-31 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-01-01 2024-12-31 0000059478 lly:A1625BritishPoundDenominatedNotesDue2043Member 2024-01-01 2024-12-31 0000059478 lly:A1.700Notesdue2049Member 2024-01-01 2024-12-31 0000059478 lly:A1.125EuroDenominatedNotesDue2051Member 2024-01-01 2024-12-31 0000059478 lly:A1.375EuroDenominatedNotesDue2061Member 2024-01-01 2024-12-31 0000059478 2024-06-30 0000059478 2025-02-14 0000059478 2023-01-01 2023-12-31 0000059478 2022-01-01 2022-12-31 0000059478 2024-12-31 0000059478 2023-12-31 0000059478 us-gaap:CommonStockMember 2021-12-31 0000059478 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000059478 us-gaap:RetainedEarningsMember 2021-12-31 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2021-12-31 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000059478 us-gaap:TreasuryStockCommonMember 2021-12-31 0000059478 us-gaap:NoncontrollingInterestMember 2021-12-31 0000059478 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000059478 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000059478 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000059478 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000059478 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000059478 us-gaap:CommonStockMember 2022-12-31 0000059478 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000059478 us-gaap:RetainedEarningsMember 2022-12-31 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2022-12-31 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000059478 us-gaap:TreasuryStockCommonMember 2022-12-31 0000059478 us-gaap:NoncontrollingInterestMember 2022-12-31 0000059478 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000059478 us-ga